Physician profile
Michael Kelly
NPI 1083685523
$1,709.74
in general payments reported to CMS, 2019-2025
5 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $17.14 · 2021: $256 · 2022: $420 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $429.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $685.23 | 2021-2025 | N/A |
| W. L. Gore & Associates, INC. | $452.07 | 2019 | |
| Nuvasive, INC. | $420.00 | 2022 | |
| Edwards Lifesciences Corporation | $108.41 | 2019 | |
| Abbott Laboratories | $44.03 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.